These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 32888683

  • 1. Update on the Management of Kawasaki Disease.
    Friedman KG, Jone PN.
    Pediatr Clin North Am; 2020 Oct; 67(5):811-819. PubMed ID: 32888683
    [Abstract] [Full Text] [Related]

  • 2. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM, Shulman ST.
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [Abstract] [Full Text] [Related]

  • 3. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
    J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
    [Abstract] [Full Text] [Related]

  • 4. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
    Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S, Newburger JW.
    Arch Dis Child; 2021 Mar 15; 106(3):247-252. PubMed ID: 32943389
    [Abstract] [Full Text] [Related]

  • 5. Kawasaki disease: Medical therapies.
    Newburger JW.
    Congenit Heart Dis; 2017 Sep 15; 12(5):641-643. PubMed ID: 28580631
    [Abstract] [Full Text] [Related]

  • 6. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Sep 15; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 7. Adjunctive therapies for Kawasaki disease.
    Campbell AJ, Burns JC.
    J Infect; 2016 Jul 05; 72 Suppl():S1-5. PubMed ID: 27241708
    [Abstract] [Full Text] [Related]

  • 8. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
    Takekoshi N, Kitano N, Takeuchi T, Suenaga T, Kakimoto N, Suzuki T, Kada TT, Shibuta S, Tachibana S, Murayama Y, Yamaga H, Suzuki H.
    JAMA Netw Open; 2022 Jun 01; 5(6):e2216642. PubMed ID: 35696166
    [Abstract] [Full Text] [Related]

  • 9. Management of acute and refractory Kawasaki disease.
    Tacke CE, Burgner D, Kuipers IM, Kuijpers TW.
    Expert Rev Anti Infect Ther; 2012 Oct 01; 10(10):1203-15. PubMed ID: 23199405
    [Abstract] [Full Text] [Related]

  • 10. Association between intravenous immunoglobulin dose and outcomes in patients with acute Kawasaki disease.
    Michihata N, Suzuki T, Yoshikawa T, Saito K, Matsui H, Fushimi K, Yasunaga H.
    Eur J Pediatr; 2022 Oct 01; 181(10):3607-3615. PubMed ID: 35925450
    [Abstract] [Full Text] [Related]

  • 11. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
    Tanaka A, Inoue M, Hoshina T, Koga H.
    J Pediatr; 2021 Sep 01; 236():95-100. PubMed ID: 34019881
    [Abstract] [Full Text] [Related]

  • 12. [Immunoglobulin therapy].
    Ogata S, Ishii M.
    Nihon Rinsho; 2014 Sep 01; 72(9):1617-22. PubMed ID: 25518412
    [Abstract] [Full Text] [Related]

  • 13. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
    Gamez-Gonzalez LB, Moribe-Quintero I, Cisneros-Castolo M, Varela-Ortiz J, Muñoz-Ramírez M, Garrido-García M, Yamazaki-Nakashimada M.
    Pediatr Int; 2018 Sep 01; 60(9):781-790. PubMed ID: 29888440
    [Abstract] [Full Text] [Related]

  • 14. Initial intravenous gammaglobulin treatment failure in Kawasaki disease.
    Wallace CA, French JW, Kahn SJ, Sherry DD.
    Pediatrics; 2000 Jun 01; 105(6):E78. PubMed ID: 10835091
    [Abstract] [Full Text] [Related]

  • 15. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.
    Matsuoka R, Furuno K, Nanishi E, Onoyama S, Nagata H, Yamamura K, Sugitani Y, Kuraoka A, Mizuno Y, Sagawa K, Honjo S, Hara T, Ohga S.
    J Pediatr; 2020 Dec 01; 227():224-230.e3. PubMed ID: 32810506
    [Abstract] [Full Text] [Related]

  • 16. Intravenous Immunoglobulin for the Treatment of Kawasaki Disease.
    Shulman ST.
    Pediatr Ann; 2017 Jan 01; 46(1):e25-e28. PubMed ID: 28079915
    [Abstract] [Full Text] [Related]

  • 17. Intravenous immunoglobulin for the treatment of Kawasaki disease in children.
    Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I.
    Cochrane Database Syst Rev; 2003 Jan 01; 2003(4):CD004000. PubMed ID: 14584002
    [Abstract] [Full Text] [Related]

  • 18. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
    Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, Zhou T, Wang Z, Martinek M, Pürerfellner H, Liu S, Krucoff MW.
    JAMA Pediatr; 2016 Dec 01; 170(12):1156-1163. PubMed ID: 27749951
    [Abstract] [Full Text] [Related]

  • 19. Dissecting Kawasaki disease: a state-of-the-art review.
    Dietz SM, van Stijn D, Burgner D, Levin M, Kuipers IM, Hutten BA, Kuijpers TW.
    Eur J Pediatr; 2017 Aug 01; 176(8):995-1009. PubMed ID: 28656474
    [Abstract] [Full Text] [Related]

  • 20. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.
    Dionne A, Burns JC, Dahdah N, Tremoulet AH, Gauvreau K, de Ferranti SD, Baker AL, Son MB, Gould P, Fournier A, Newburger JW, Friedman KG.
    Pediatrics; 2019 Jun 01; 143(6):. PubMed ID: 31048414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.